Can reducing cosmetic substances help prevent chromate contact allergy?

Area of Science:

• Environmental Science
• Dermatology
• Toxicology

Background:

• Allergic contact dermatitis from hexavalent chromium (Cr(VI)) is severe and challenging to manage.
• While primary prevention is key, secondary prevention strategies are crucial for managing Cr(VI) dermatitis after sensitization.
• Existing barrier creams have not proven effective against Cr(VI).

Purpose of the Study:

• To assess the efficacy of various reducing agents in transforming Cr(VI) to Cr(III) under experimental conditions.
• To identify potential candidates for developing a barrier cream to prevent or treat Cr(VI) dermatitis.

Main Methods:

• Investigated the Cr(VI) reducing capacity of acetylcysteine, cysteine, dihydroxyacetone, glutathione, and iron sulfate in aqueous solutions.
• Assessed the reducing potential of selected agents (acetylcysteine, dihydroxyacetone, glutathione, iron sulfate) on Cr(VI) in cement extracts.
• Quantified Cr(VI) levels using the diphenyl carbazide spot test.

Main Results:

• All tested chemicals demonstrated a capacity to reduce Cr(VI) levels in both solutions and cement extracts.
• Iron sulfate exhibited the most significant reducing effect on Cr(VI).

Conclusions:

• The study confirmed that all evaluated chemicals possess reducing properties against Cr(VI).
• These findings support further investigation of these agents, particularly iron sulfate, for barrier cream applications.